Literature DB >> 23800036

Peptidergic regulation of plasminogen activator inhibitor-1 gene expression in vivo.

N A Gingles1, H Bai, L A Miles, R J Parmer.   

Abstract

BACKGROUND: The mechanisms by which PAI-1 biosynthesis is altered during stress have not been fully elucidated. Studies suggest a major role for neuro-peptidergic modulation of the stress response by PACAP (pituitary adenylate cyclase-activating polypeptide), a member of the VIP/secretin/glucagon family.
OBJECTIVE: We tested the hypothesis that PACAP regulates PAI-1 biosynthesis during stress in vivo.
METHODS: PAI-1 gene expression was monitored by RT-PCR in adrenal glands harvested from C57BL/6J mice that were unstressed, or subjected to restraint stress for 2 h, or treated with PACAP.
RESULTS: PAI-1 mRNA expression was markedly increased in adrenals from stressed mice. Restraint stress resulted in much smaller increments in adrenal tPA mRNA, suggesting that local adrenal tPA/PAI-1 biosynthetic balance is markedly altered by stress. The observed increases in PAI-1mRNA during stress were substantially blunted (55 ± 4%, P < 0.001) by pretreatment with the specific PACAP receptor antagonist, PACAP6-38, compared with pretreatment with vehicle. Administration of the agonist PACAP1-38 alone resulted in a dose-dependent increase in tissue PAI-1 mRNA. PACAP1-38 administration also resulted in substantial increases in plasma PAI-1 antigen and active PAI-1 concentrations that were significantly greater in male mice than in female mice.
CONCLUSIONS: We conclude that adrenal PAI-1 mRNA expression is markedly increased by stress, and that the PACAP peptidergic signaling pathway plays a major role in mediating the stress-induced increase in PAI-1 biosynthesis.
© 2013 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  Physiological; Pituitary adenylate cyclase-activating polypeptide; Plasminogen activator inhibitor-1; Stress; Sympathetic Nervous System; tissue plasminogen activator

Mesh:

Substances:

Year:  2013        PMID: 23800036      PMCID: PMC3965269          DOI: 10.1111/jth.12333

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  41 in total

1.  Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production.

Authors:  N J Brown; K S Kim; Y Q Chen; L S Blevins; J H Nadeau; S G Meranze; D E Vaughan
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

2.  Multiple transmitter control of catecholamine secretion in rat adrenal medulla.

Authors:  A R Wakade
Journal:  Adv Pharmacol       Date:  1998

Review 3.  The adipocyte and hemostatic balance in obesity: studies of PAI-1.

Authors:  D J Loskutoff; F Samad
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-01       Impact factor: 8.311

4.  The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles.

Authors:  Qijiao Jiang; Neill A Gingles; Marc A Olivier; Lindsey A Miles; Robert J Parmer
Journal:  Blood       Date:  2011-05-19       Impact factor: 22.113

5.  Cell-surface actin binds plasminogen and modulates neurotransmitter release from catecholaminergic cells.

Authors:  Lindsey A Miles; Nicholas M Andronicos; Nagyung Baik; Robert J Parmer
Journal:  J Neurosci       Date:  2006-12-13       Impact factor: 6.167

6.  Molecular regulation of gene expression of catecholamine biosynthetic enzymes by stress: sympathetic ganglia versus adrenal medulla.

Authors:  Esther L Sabban; Bistra B Nankova; Lidia I Serova; Richard Kvetnansky; Xiaoping Liu
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

7.  Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.

Authors:  P Carmeliet; J M Stassen; L Schoonjans; B Ream; J J van den Oord; M De Mol; R C Mulligan; D Collen
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.

Authors:  J Schneiderman; M S Sawdey; M R Keeton; G M Bordin; E F Bernstein; R B Dilley; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  A non-cholinergic transmitter, pituitary adenylate cyclase-activating polypeptide, utilizes a novel mechanism to evoke catecholamine secretion in rat adrenal chromaffin cells.

Authors:  D A Przywara; X Guo; M L Angelilli; T D Wakade; A R Wakade
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

10.  Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men.

Authors:  K Räikkönen; R Lassila; L Keltikangas-Järvinen; A Hautanen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-03       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.